ORBIMED ADVISORS LLC
Top Portfolio Positions
107 positions ·
$5,411,268,746 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MYGN |
Myriad Genetics Inc
Healthcare
|
125,000,000 | $562,500,000 | 10.39% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
15,518,492 | $488,832,498 | 9.03% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
7,959,538 | $312,013,889 | 5.77% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
82,010,995 | $303,440,681 | 5.61% | |
| MDXH |
MDxHealth SA
Healthcare
|
124,306,000 | $285,903,800 | 5.28% | |
| LLY |
ELI LILLY & Co
Healthcare
|
236,800 | $217,801,536 | 4.02% | |
| BSX |
Boston Scientific Corp
Healthcare
|
2,382,100 | $149,476,775 | 2.76% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
3,530,702 | $141,545,843 | 2.62% | |
| AZN |
Astrazeneca PLC
Healthcare
|
670,200 | $132,176,844 | 2.44% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
3,637,887 | $108,590,926 | 2.01% |
Portfolio Trend
25 quarters · across all stocks
Holdings in SNDX
Shares Held
Position Value (USD)
18 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,479,328 | 962,300 | Shares | Defined | 2026-05-15 | |
| 2024-09-30 | $37,062,025 | 1,925,300 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $39,526,409 | 1,925,300 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $41,626,200 | 1,749,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $37,795,890 | 1,749,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,643,680 | 1,284,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,957,923 | 2,530,240 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,150,576 | 1,711,675 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,065,425 | 2,006,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $48,216,195 | 2,006,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $44,700,292 | 2,323,300 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $37,511,254 | 2,158,300 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $43,370,657 | 1,981,300 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,642,366 | 190,600 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $26,040,816 | 1,170,900 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $16,148,916 | 1,094,100 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $16,214,562 | 1,094,100 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,181,300 | 290,000 | Shares | Defined | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||